Ko, Hyo Rim
Ahn, So Yoon
Chang, Yun Sil
Hwang, Inwoo
Yun, Taegwan
Sung, Dong Kyung
Sung, Se In
Park, Won Soon
Ahn, Jee-Yin
Funding for this research was provided by:
National Research Foundation of Korea (2016R1A5A2945889, NRF-2017R1A2B4001846, NRF-2014R1A1A3051220)
samsung biomedical research institute grant (SMX1161311)
Article History
Received: 4 June 2018
Revised: 2 October 2018
Accepted: 17 October 2018
First Online: 21 November 2018
Ethics approval
: This study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Sungkyunkwan University School of Medicine (SUSM) (code 17-6-4-1). SUSM is an Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International; No. 001004)-accredited facility and abide by the Institute of Laboratory Animal Resources (ILAR) guide. All experimental procedures were carried out in accordance with the regulations of the IACUC guideline of Sungkyunkwan University.
: Not applicable.
: Won Soon Park and Yun Sil Chang declare potential conflicts of interest arising from a filed or issued patent titled “Composition for treating intraventricular hemorrhage in preterm infants comprising mesenchymal stem cells” as co-inventors, not as patentees.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.